The Analytic for Hemodynamic Instability (AHI) from Weil Institute partner Fifth Eye, Inc. provides clinically significant lead time in predicting onset of instability before vital signs.
Read More
Fifth Eye's AHI System is the only FDA-cleared medical device software of its kind, detecting hemodynamic instability that can signal patient decompensation ahead of vital signs.
Read More